N‐[1‐(Penta­fluoro­phenyl)­ethyl]­acetamide

The title compound, C₁₀H₈F₅NO, crystallizes as a racemate with four symmetry‐independent mol­ecules in the asymmetric unit. The four mol­ecules form two hydrogen‐bonded pairs. Each pair is a building unit of an independent C(4) chain propagating parallel to the ab plane.     

8‐Chloro‐7‐(2,6‐di­chloro­benzyl)‐1,3‐di­methyl‐7H‐purine‐2,6(1H,3H)‐dione

The title compound, C₁₄H₁₁Cl₃N₄O₂, consists of two planar fragments which are nearly perpendicular to one another. The crystal packing is controlled by intra‐ and intermolecular C—H·O hydrogen bonds, and Cl·phenyl‐ring‐centroid and weak stacking interactions.     

2,5‐Di‐2‐thienyl­thia­zolo­[4,5‐d]­thia­zole

The mol­ecules of the title compound, C₁₂H₆N₂S₄, lie on centres of symmetry. The thio­phene and thia­zole rings are almost planar and their planes make a dihedral angle of 1.68 (8)°. In the crystal structure, there is a relatively short intermolecular S⋯S contact distance of 3.5786 (9) Å.     

4‐[3‐(3,4‐Di­methoxy­phenyl)­prop‐2‐enoyl]­phenyl methacryl­ate and 4‐[3‐(2‐bromo­phenyl)­prop‐2‐enoyl]­phenyl methacryl­ate

Chalcones (α,β‐unsaturated ketones) are effective antitumour agents. It has been proved that having halogen or methoxy groups substituted in various positions of the phenyl ring enhances the activity of chalcones many times. The title compounds, C₂₁H₂₀O₅ and C₁₉H₁₅BrO₃, respectively, were chosen for crystallographic study in order to determine their structures and conformations. In both compounds, the keto group is in the s‐cis conformation and is almost planar. There are weak intramolecular interactions in both structures.     

trans‐Bis­[1‐methyl‐3‐(p‐nitro­phenyl)­triazenido 1‐oxide‐κ2N3,O]­di­pyridine­nickel(II)

In the centrosymmetric title complex, [Ni(C₇H₇N₄O₃)₂(C₅H₅N)₂], the coordination geometry about the Ni²⁺ ion is octahedral, with two deprotonated 1‐methyl‐3‐(p‐nitro­phenyl)­triazenide 1‐oxide ions, viz. [O₂N­C₆H₄­NNN(O)­CH₃]^?, acting as bidentate ligands (four‐electron donors). Two neutral pyridine (py) mol­ecules complete the coordination sphere in positions trans to each other. The triazenide 1‐oxide ligand is almost planar, the largest interplanar angle of 8.80 (12)° being between the phenyl ring of the p‐nitro­phenyl group and the plane defined by the N₃O moiety. The Ni—N_triazenide, Ni—O and Ni—N_py distances are 2.0794 (16), 2.0427 (13) and 2.1652 (18) Å, respectively.     

6‐(3,4‐Di­fluoro­benzoyl)‐3‐[2‐(4‐pyridyl)­ethyl]‐1,3‐benzo­thia­zol‐2(3H)‐one

A new type of benzo­thia­zolinone derivative with potential pharmacological activity, viz. 6‐(3,4‐di­fluoro­benzoyl)‐3‐[2‐(4‐pyridyl)­ethyl]‐1,3‐benzo­thia­zol‐2(3H)‐one, C₂₁H₁₄F₂N₂O₂S, has been prepared and studied by NMR, IR and single‐crystal X‐ray diffraction techniques. The mol­ecule is not planar, the pyridine and di­fluoro­benzene moieties being located above and below the benzo­thia­zole ring system. The carbonyl O atoms are involved in an intramolecular hydrogen‐bond‐type interaction.     

1‐{5‐[2‐(Tri­fluoro­methyl)­phenyl]‐1,3,4‐thia­diazol‐2‐yl}guanidinium chloride

In the title compound, C₁₀H₉F₃N₅S⁺·Cl^?, which was developed as a potential anticonvulsant, the phenyl ring, the thia­diazo­le ring and the guanidinium moiety are all planar. There is a dihedral angle of 48.9 (1)° between the thia­diazole and phenyl rings which prevents steric hindrance arising from the π bonds within the former, and the tri­fluoro­phenyl moiety attached to the latter. The thia­diazole and guanidinium moieties are twisted by 12.7 (2)° with respect to each other. An extensive network of hydrogen bonds, predominantly involving the chloride ion, maintains the crystal structure.     

Tri­carbonyl­[(6a,7,8,9,10a‐η)‐3,3‐di­methyl‐3H‐benzo­[f]­chromene]chromium

The title compound, [Cr(C₁₅H₁₄O)(CO)₃], is a chromene complexed with tri­carbonyl­chromium and it exhibits photochromic properties. The molecular geometry is compared to that of two similar complexes. The analysis results indicate that complexation has minor effects on the chromene structure.     

3‐[4‐(4‐Fluoro­phenyl)­piperazin‐1‐yl­methyl]‐5‐methyl‐1,3‐benzoxazol‐2(3H)‐one and 3‐[4‐(2‐fluoro­phenyl)­piperazin‐1‐yl­methyl]‐5‐methyl‐1,3‐benzoxazol‐2(3H)‐one

The title compounds, both C₁₉H₂₀FN₃O₂, contain essentially planar benzoxazolinone ring systems, within which the C—N bond distances and angles do not differ significantly between the two compounds. In both cases, the piperazine ring adopts an almost perfect chair conformation and the benzoxazo­l­inone ring system lies nearly perpendicular to it. The structures contain intermolecular C—H⋯O contacts, and the interactions between the benzoxazolinone and fluoro­phenyl­piperazine portions of the mol­ecules are segregated.     

Syntheses of N‐[3‐(1‐methyl‐1H‐2‐imidazolyl)propyl]benzamides and N‐[3‐(1‐methyl‐1H‐2‐imidazolyl)propyl]benzenesulfonamides

A series of substituted N‐(4‐substituted‐benzoyl)‐N‐[3‐(1‐methyl‐1H‐imidazol‐2‐yl)propyl]amines ( 13 ) and N‐arylsulfonyl‐N‐[3‐(1‐methyl‐1H‐imidazol‐2‐yl)propyl]amines ( 14 ) were prepared from the reaction of 3‐(1‐methyl‐1H‐imidazol‐2‐yl)propan‐1‐amine ( 7 ) with substituted benzoyl chloride or substituted‐benzene sulfonyl chloride respectively. Compound 7 was prepared by two independent methods.     

Bis­[2‐(di­phenyl­phosphinoyl)­benzene] di­sulfide

The title compound, [2‐Ph₂P(O)C₆H₄S]₂ or C₃₆H₂₈O₂P₂S₂, obtained by electrochemical oxidation of 2‐(di­phenyl­phosphino)­benzene­thiol, has twofold crystallographic symmetry. Principal dimensions include S—S 2.0212 (15) Å, S—C 1.786 (3) Å and C—S—S—C 81.34 (14)°.     

3‐(2‐Furyl)‐6‐(4‐methyl­phenyl)‐7H‐1,2,4‐triazolo­[3,4‐b][1,3,4]thia­diazine and its 6‐phenyl analogue

In the title compounds, C₁₅H₁₂N₄OS, (I), and C₁₄H₁₀N₄OS, (II), the thia­diazine ring adopts a skew‐boat conformation, while the triazole and furyl rings are essentially planar. The phenyl group is twisted by 33.5 (2) and 47.9 (1)° out of the triazole‐ring plane in (I) and (II), respectively.     

[4‐(Tri­fluoro­methyl)­phenyl]­aceto­nitrile

The crystal structure of the title compound, C₉H₆F₃N, at 123 K contains mol­ecules linked together via several C—H?F and C—H?N contacts, the strongest of which are 2.58 and 2.65 Å, respectively. Apparently, an F atom in the CF₃ group is able to compete with a cyano N atom for aromatic H atoms but is less prone to interact with the more acidic methyl­ene H atoms. The Ph–CH₂CN torsion angle is ?6.4 (2)° and the planar phenyl ring exhibits a typical deformation of the endo angles at the ipso‐C atoms, due to the difference in the electron‐withdrawing power of the CF₃ and CH₂CN substituents.     

Ethyl N‐[2‐(hydroxy­acetyl)­phenyl]­carbamate,ethyl N‐[2‐(hydroxy­acetyl)‐4‐iodo­phenyl]­carbamate and ethyl N‐[2‐(hydroxy­acetyl)‐4‐methyl­phenyl]­carbamate

In ethyl N‐[2‐(hydroxy­acetyl)phenyl]carbamate, C₁₁H₁₃NO₄, all of the non‐H atoms lie on a mirror plane in the space group Pnma; the mol­ecules are linked into simple chains by a single C—H⋯O hydrogen bond. The mol­ecules of ethyl N‐[2‐(hydroxy­acetyl)‐4‐iodo­phenyl]carbamate, C₁₁H₁₂INO₄, are linked into sheets by a combination of O—H⋯I and C—H⋯O hydrogen bonds and a dipolar I⋯O contact. Ethyl N‐­[2‐(hydroxy­acetyl)‐4‐methyl­phenyl]carbamate, C₁₂H₁₅NO₄, crystallizes with Z′ = 2 in the space group P; pairs of mol­ecules are weakly linked by an O—H⋯O hydrogen bond and these aggregates are linked into chains by two independent aromatic π–π stacking inter­actions.     

1‐[4‐(Methyl­sulfonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole derivatives

Three related compounds containing a pyrazole moiety with vicinal phenyl rings featuring a methyl­sulfonyl substituent are described, namely 3‐methyl‐1‐[4‐(methyl­sulfonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole, C₁₇H₁₆N₂O₂S, ethyl 1‐[4‐(methyl­sul­fonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole‐3‐carboxyl­ate, C₁₉H₁₈N₂O₄S, and 1‐[4‐(methyl­sulfonyl)­phenyl]‐3‐[3‐(morpholino)­phenoxy­methyl]‐5‐phenyl‐1H‐pyrazole, C₂₇H₂₇N₃O₄S. The design of these compounds was based on celecoxib, a selective cyclo­oxy­genase‐2 (COX‐2) inhibitor, in order to study the influence of various substituents on COX‐2 and 5‐lipoxy­genase (5‐LOX) inhibition.     

4‐Methyl‐2‐[N‐(3,4‐methyl­ene­dioxy­benzyl­idene)hydrazino]­thia­zole and its reduction product, 4‐methyl‐2‐[N‐(3,4‐methyl­ene­dioxybenzyl­idene)hydrazono]‐4,5‐di­hydro­thia­zole

The crystal structures of 4‐methyl‐2‐[N‐(3,4‐methyl­ene­dioxybenzyl­idene)hydrazino]­thia­zole, C₁₂H₁₁N₃O₂S, and its reduction product 4‐methyl‐2‐[N‐(3,4‐methyl­ene­dioxybenzyl­idene)hydrazono]‐4,5‐di­hydro­thia­zole, C₁₂H₁₃N₃O₂S, have been determined and compared. In the reduction product, the tautomer observed bears an H atom on the exocyclic N atom. Both compounds form hydrogen‐bonded dimers over centers of inversion.     

Bis­[bis­(di­phenyl­phosphino­methyl)­phenyl­phosphine]­di­chloro­tetra­gold(I) bis­[chloro­tris­(penta­fluoro­phenyl)­aurate(III)]

The cation of the title compound, [Au₄(PPh₂CH₂PPhCH₂PPh₂)₂Cl₂][Au(C₆F₅)₃Cl]₂ or [Au₄Cl₂(C₃₂H₂₉P₃)₂][AuCl(C₆F₅)₃]₂, displays a rhomboidal geometry for the Au atoms, with short Au?Au distances of 3.104 (2) and 3.185 (1) Å; the linear coordination at the Au^I atoms is distorted: P—Au—P 164.7 (2)° and P—Au—Cl 170.67 (11)°. The anion shows the expected square‐planar geometry at Au^III, with the Au atom 0.022 (5) Å out of the plane of the four donor atoms.     

Chloro(1‐{3‐[2‐(di­phenyl­phos­phanyl‐κP)­ethyl]‐η6‐benzyl}‐3,5‐di­methyl‐1H‐pyrazole‐κN2)­ruthenium(II) tri­fluoro­methane­sulfonate

To address the question of the role of chirality at the metal in enantioselective catalysis, a pseudo‐tetrahedral three‐legged piano‐stool complex has been prepared, i.e. [RuCl(C₂₆H₂₇N₂P)](CF₃SO₃). Anchoring a phosphine and a pyrazole tether to an arene (PArN) yields, after η⁶:η¹:η¹ coordination to ruthenium, [{η⁶:η¹:η¹‐(PArN)}RuCl]⁺ as a 1:1 mixture of enantiomers. Unfortunately, all attempts to resolve the enantiomers failed. The structure solution revealed the presence of racemic crystals.     

3,6‐Di­chloro‐4‐[2‐(4‐thia­morpholino)­ethanesulfanyl]­pyridazine and 3,6‐bis­(pyrazol‐1‐yl)‐4‐[2‐(4‐thia­mor­pho­lino)­ethanesulfanyl]­pyridazine

The trans–trans conformations adopted by the derivatized bis­(bidentate) chelating N₄‐donor ligand 3,6‐bis­(pyrazol‐1‐yl)‐4‐[2‐(4‐thia­morpholino)­ethanesulfanyl]­pyridazine, C₁₆H₁₉N₇S₂, and an intermediate in its formation, 3,6‐di­chloro‐4‐[2‐(4‐thia­morpholino)­ethanesulfanyl]­pyridazine, C₁₀H₁₃Cl₂N₃S₂, con­trast with the cis–cis conformation found previously for 3,6‐bis­(thio­phen‐2‐yl)­pyridazine [Ackers, Blake, Hill & Hubberstey (2002). Acta Cryst. C 58 , o640–o641], which places all four heteroatoms on the same side of the mol­ecule.     

1‐(2‐{4‐[6‐Hydro­xy‐2‐(4‐hydroxy­phenyl)­benzo­[b]­thiol‐3‐yl­carbonyl]­phenoxy}ethyl)­piperidinium chloride

The title compound, raloxifene hydro­chloride, C₂₈H₂₈NO₄S⁺·Cl^?, belongs to the benzo­thio­phene class of antiosteoporotic drugs. In the molecular cation, the 2‐phenol ring sustains a dihedral angle of 45.3 (1)° relative to the benzo­[b]­thio­phene system. The benzo­[b]­thio­phene and phenyl ring planes are twisted with respect to the carbonyl plane, with the smallest twist component occurring between the phenyl and carbonyl planes. The N atom bears the positive charge in the molecular cation and the piperidine ring adopts an almost perfect chair conformation. The Cl^? anion is involved in the formation of N—H?Cl and O—H?Cl intermolecular hydrogen bonds, which lead to the formation of a layer of molecular cations.